Skip to main content
Premium Trial:

Request an Annual Quote

Debiopharm Group Taps Quartz Bio to Provide Bioinformatics Support for Biomarker Projects


Last week, Quartz Bio said that it had been selected to provide bioinformatics support for biomarker projects conducted by the Debiopharm group, a Swiss-based biopharmaceutical company.

Under the terms of the one-year agreement, the Merck Serono spinoff (BI 9/7/2012) will provide computational analyses for Debiopharm projects in areas such as preclinical next-generation sequencing and clinical biomarker data analyses.

The financial details of the deal are not being disclosed.